SG Americas Securities LLC grew its position in Henry Schein, Inc. (NASDAQ:HSIC) by 128.5% in the 4th quarter, according to its most recent disclosure with the SEC. The fund owned 29,192 shares of the company’s stock after buying an additional 16,418 shares during the period. SG Americas Securities LLC’s holdings in Henry Schein were worth $2,040,000 as of its most recent SEC filing.
A number of other institutional investors have also recently modified their holdings of the business. Thrivent Financial For Lutherans raised its holdings in Henry Schein by 3.8% in the second quarter. Thrivent Financial For Lutherans now owns 3,000 shares of the company’s stock worth $549,000 after buying an additional 110 shares during the last quarter. Colony Group LLC raised its holdings in Henry Schein by 1.3% in the second quarter. Colony Group LLC now owns 12,734 shares of the company’s stock worth $2,331,000 after buying an additional 158 shares during the last quarter. QS Investors LLC raised its holdings in Henry Schein by 9.6% in the second quarter. QS Investors LLC now owns 4,225 shares of the company’s stock worth $773,000 after buying an additional 369 shares during the last quarter. Stifel Financial Corp raised its holdings in Henry Schein by 2.2% in the second quarter. Stifel Financial Corp now owns 26,458 shares of the company’s stock worth $4,847,000 after buying an additional 578 shares during the last quarter. Finally, Trust Co. of Vermont raised its holdings in Henry Schein by 56.7% in the third quarter. Trust Co. of Vermont now owns 1,702 shares of the company’s stock worth $140,000 after buying an additional 616 shares during the last quarter. 90.93% of the stock is owned by institutional investors and hedge funds.
Henry Schein, Inc. (NASDAQ HSIC) opened at $71.80 on Tuesday. The company has a current ratio of 1.55, a quick ratio of 0.86 and a debt-to-equity ratio of 0.30. Henry Schein, Inc. has a twelve month low of $65.28 and a twelve month high of $93.50. The firm has a market cap of $11,669.56, a P/E ratio of 20.86, a PEG ratio of 1.91 and a beta of 1.00.
In other news, Director Barry J. Alperin sold 5,796 shares of the business’s stock in a transaction that occurred on Friday, December 1st. The shares were sold at an average price of $70.76, for a total transaction of $410,124.96. Following the completion of the transaction, the director now directly owns 48,172 shares of the company’s stock, valued at $3,408,650.72. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 1.19% of the stock is owned by insiders.
About Henry Schein
Henry Schein, Inc is a provider of healthcare products and services primarily to office-based dental, animal health and medical practitioners. The Company operates through two segments: healthcare distribution, and technology and value-added services. The healthcare distribution segment distributes consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.
Want to see what other hedge funds are holding HSIC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Henry Schein, Inc. (NASDAQ:HSIC).
Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.